Log In
Print
BCIQ
Print
Print this Print this
 

ReS19-T

  Manage Alerts
Collapse Summary General Information
Company reMYND N.V.
DescriptionSmall molecule against an undisclosed target that prevents neurotoxicity associated with microtubule-associated protein tau
Molecular Target Microtubule-associated protein tau (tau) (MAPT) (FTDP-17)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner

Roche


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today